相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Muscle contraction increases the in vivo structural strength to the same degree in osteopenic and normal rat tibiae
Lars Nordsletten et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Training increases the in vivo strength of the lower leg: An experimental study in the rat
Lars Nordsletten et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
The effect of thiazolidinediones on adiponectin serum level: a meta-analysis
N. Riera-Guardia et al.
DIABETES OBESITY & METABOLISM (2008)
Relationships between fat and bone
I. R. Reid
OSTEOPOROSIS INTERNATIONAL (2008)
Skeletal consequences of thiazolidinedione therapy
A. Grey
OSTEOPOROSIS INTERNATIONAL (2008)
The peroxisome proliferator-activated receptor-γ agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women:: A randomized, controlled trial
Andrew Grey et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Serum adiponectin and bone mineral density in women
J. B. Richards et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Effect of PPAR-γ agonist on adiponectin levels in the metabolic syndrome:: Lessons from the high fructose fed rat model
Yehonatan Sharabi et al.
AMERICAN JOURNAL OF HYPERTENSION (2007)
PPAR agonists odulate human osteoclast formation and activity in vitro
B. Y. Chan et al.
BONE (2007)
Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men
Subhashini Yaturu et al.
DIABETES CARE (2007)
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Steven E. Kahn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Thiazolidinedione use and bone loss in older diabetic adults
Ann V. Schwartz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Nutrition-related peptides and bone Homeostasis
IR Reid et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Short-term pioglitazone treatment prevents free fatty acid-induced hepatic insulin resistance in normal rats: Possible role of the resistin and adiponectin
GY Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Stimulation of resorption in cultured mouse calvarial bones by thiazolidinediones
AM Schwab et al.
ENDOCRINOLOGY (2005)
Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast
K Oshima et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia
KK Koh et al.
DIABETES CARE (2005)
Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation
AA Ali et al.
ENDOCRINOLOGY (2005)
Oxysterols regulate differentiation of mesenchymal stem cells: Pro-bone and anti-fat
HT Kha et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors
T Akune et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Enhanced bone formation in lipodystrophic PPARγhyp/hyp mice relocates haematopoiesis to the spleen
TA Cock et al.
EMBO REPORTS (2004)
Fenofibrate lowers adiposity and corrects metabolic abnormalities, but only partially restores endothelial function in dietary obese rats
EK Naderali et al.
ATHEROSCLEROSIS (2004)
PPARα ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats
T Toyama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Bone is a target for the antidiabetic compound rosiglitazone
SO Rzonca et al.
ENDOCRINOLOGY (2004)
Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis
MA Sorocéanu et al.
JOURNAL OF ENDOCRINOLOGY (2004)
Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone)
V Sottile et al.
CALCIFIED TISSUE INTERNATIONAL (2004)
PPAR agonists amplify iNOS expression while inhibiting NF-κB:: implications for mesangial cell activation by cytokines
E Cernuda-Morollón et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling
JO Gordeladze et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2002)
Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization
JE Reseland et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance
CJ de Souza et al.
DIABETES (2001)
Activation of peroxisome proliferator-activated receptor-γ pathway inhibits osteoclast differentiation
G Mbalaviele et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Peroxisome proliferator-activated receptor activators modulate the osteoblastic maturation of MC3T3-E1 preosteoblasts
SM Jackson et al.
FEBS LETTERS (2000)
Cloning and function of rabbit peroxisome proliferator-activated receptor δ/β in mature osteoclasts
H Mano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
